Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

What is the role of PCSK9 inhibitors in treating hypercholesterolemia?

What is the role of PCSK9 inhibitors in treating hypercholesterolemia? ABSTRACT PCSK9 inhibitors are a novel medical therapy for treating hypercholesterolemia. This article reviews the basic properties of PCSK9 inhibitors, including their mechanism of action, indications, contraindications, adverse reactions, and efficacy. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of the American Academy of PAs Wolters Kluwer Health

What is the role of PCSK9 inhibitors in treating hypercholesterolemia?

Journal of the American Academy of PAs , Volume 31 (6) – Jun 1, 2018

Loading next page...
 
/lp/wolters-kluwer-health/what-is-the-role-of-pcsk9-inhibitors-in-treating-hypercholesterolemia-DsfPAPDQjm

References (9)

Publisher
Wolters Kluwer Health
ISSN
1547-1896
eISSN
0893-7400
DOI
10.1097/01.JAA.0000532126.38283.02
pmid
29846311
Publisher site
See Article on Publisher Site

Abstract

ABSTRACT PCSK9 inhibitors are a novel medical therapy for treating hypercholesterolemia. This article reviews the basic properties of PCSK9 inhibitors, including their mechanism of action, indications, contraindications, adverse reactions, and efficacy.

Journal

Journal of the American Academy of PAsWolters Kluwer Health

Published: Jun 1, 2018

There are no references for this article.